BC has been classified into several biologically distinct subtypes: luminal A, luminal B, human epidermal growth factor receptor 2 (HER2)-enriched (HER2), basal-like, and normal-like by gene expression profiling analysis (1, 2), requiring different treatment strategies. This evidence concerns the gene ERBB2 and breast cancer.